Verrupatch 3.75 mg cutaneous patches
Verrupatch is a cutaneous patch treatment indicated for the gradual removal of common and plantar warts through the localised application of salicylic acid.
Each patch contains 3.75 mg of salicylic acid. Excipients: propylene glycol (E-1520), Karaya gum, polyethylene glycol 300, quaternium-15 and Macrogol 300.
Do not use in children aged under 2 years of age. In children 2 and to under 12 years, do not use without medical advice and avoid prolonged use in children.
It is presented as circular cutaneous patches, 6 mm in diameter, beige in colour and covered by a blue polyethene film that retains moisture, producing an occlusive effect. Each pack contains 20 patches arranged in two airtight, moisture-resistant sachets, with 10 patches each. To secure the patches in the correct position, 20 skin-compatible adhesive strips are included. A file is also provided to remove residue from the wart’s surface.
Do not swallow. Cutaneous use (on the skin only). Avoid contact with healthy skin. Avoid contact with the eyes. In case of accidental application to the eyes, rinse with plenty of water. People with diabetes or poor circulation should consult their doctor before using this medicine.
For more information, see the package leaflet on CIMA
*AI-generated images reviewed by the Laboratorios Viñas team.